Penserra Capital Management LLC Rigel Pharmaceuticals Inc Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$2.36 - $3.57 $9,204 - $13,923	-3,900 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.5 - $4.5 $87 - $112	25 Added 0.65%	3,900 $14,000
Q2 2021 Aug 12, 2021	BUY	$3.09 - $4.54 $30 - $45	10 Added 0.26%	3,875 $16,000
Q1 2021 May 13, 2021	SELL	$3.35 - $4.93 $552 - $813	-165 Reduced 4.09%	3,865 $13,000
Q4 2020 Feb 12, 2021	BUY	$2.35 - $3.74 $6,091 - $9,694	2,592 Added 180.25%	4,030 $14,000
Q3 2020 Nov 13, 2020	BUY	$1.78 - $4.13 $2,559 - $5,938	1,438 New	1,438 $3,000

335K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $3.72B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.